BioCentury
ARTICLE | Company News

Teva sales and marketing update

December 11, 2000 8:00 AM UTC

TEVA and partner Aventis S.A. (AVE, Strasbourg, France) began U.K. sales of Copaxone glatiramer acetate to reduce the frequency of relapses in relapsing-remitting multiple sclerosis. ...